Encore: Patient and Family Symposium First Episode 4 of 4
Update: 2022-11-01
Description
A Symposium specifically developed for Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers.
Distinguished members and keynote speakers provide insight as to what impacts the patient and families on both quality and economic topics, what role leadership plays in creating the right culture for patient-centered care, and how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections.
Kathy Bischoff, C. diff. Survivor
My C. diff. Journey
Renata Johnson, C. diff. Survivor
My C. diff. Journey
Paul Feuerstadt, MD - review
Barbara McGovern, MD, “Treatment of recurrent C. difficile infection with SER-109, an investigational microbiome drug.
Distinguished members and keynote speakers provide insight as to what impacts the patient and families on both quality and economic topics, what role leadership plays in creating the right culture for patient-centered care, and how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections.
Kathy Bischoff, C. diff. Survivor
My C. diff. Journey
Renata Johnson, C. diff. Survivor
My C. diff. Journey
Paul Feuerstadt, MD - review
Barbara McGovern, MD, “Treatment of recurrent C. difficile infection with SER-109, an investigational microbiome drug.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
